| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |